Glutamic Pyruvic Transaminase (ALT)
| Catalog number: | B2013785 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 kU |
| Molecular Weight or Concentration: | 100 U/mg |
| Supplied as: | Powder |
| Applications: | molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Glutamic Pyruvic Transaminase |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Sakagishi Y. [Alanine aminotransferase (ALT)] Nihon Rinsho. 1995 May;53(5):1146-50.
- Senior JR. Alanine aminotransferase: a clinical and regulatory tool for detecting liver injury-past, present, and future Clin Pharmacol Ther. 2012 Sep;92(3):332-9.
- Sookoian S, Pirola CJ. Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine World J Gastroenterol. 2015 Jan 21;21(3):711-25.
- Mohammad M, Alaoui-Ismaili Z, Arvig MD, Barzanji AF. Increased liver markers in rhabdomyolysis in a young recruit from the field trip Ugeskr Laeger. 2023 Mar 6;185(10):V11220736.
- Yoneda K. [Aspartate aminotransferase (glutamic oxalacetic transaminase) and alanine aminotransferase (glutamic pyruvic transaminase)] Rinsho Byori. 2001 Nov;Suppl 116:72-80.
- Pacifico L, Ferraro F, Bonci E, Anania C, Romaggioli S, Chiesa C. Upper limit of normal for alanine aminotransferase: quo vadis? Clin Chim Acta. 2013 Jun 25;422:29-39.
- Raynor A, Soavelomandroso A, Robert-Mercier T, Valla D, Peoch K, Raulet-Bussian C. [Usual transaminase values: should they be reviewed and adjusted?] Ann Biol Clin (Paris). 2022 Jun 30;80(3):213-222.
- Bruguera M. Practical guidelines for examination of adults with asymptomatic hypertransaminasaemia Gastroenterol Hepatol. 2017 Feb;40(2):99-106.
- Lee WM, Larrey D, Olsson R, Lewis JH, Keisu M, Auclert L, Sheth S. Hepatic findings in long-term clinical trials of ximelagatran Drug Saf. 2005;28(4):351-70.
